GLP-1 weight loss injections at a med spa: what patients need to know

GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and compounded alternatives — have become one of the most requested services at medical spas and weight management clinics. With that demand has come a wide range in provider quality: practices doing this right, and practices doing it in ways that put patients at risk. Here's how to tell the difference.

What GLP-1 medications actually do

GLP-1 (glucagon-like peptide-1) receptor agonists work by mimicking a hormone released after eating. They:

• Slow gastric emptying — food moves through the stomach more slowly, producing prolonged fullness
• Reduce appetite — act on hypothalamic receptors to reduce hunger signals
• Lower blood glucose — originally developed for type 2 diabetes management (hence Ozempic)
• Promote weight loss — clinical trials show 10–22% body weight reduction over 68 weeks for semaglutide; similar or greater for tirzepatide

These are prescription medications. They are not supplements, wellness shots, or aesthetic treatments — they are drugs with real mechanisms and real side effects that require clinical monitoring.

Branded vs. compounded GLP-1

The FDA-approved branded medications (Ozempic, Wegovy, Mounjaro, Zepbound) are manufactured under strict quality standards. During the shortage period that began in 2022, compounding pharmacies have produced alternative formulations:

• Compounded semaglutide — not FDA-approved but legal during shortage periods; quality varies significantly by pharmacy
• Compounded tirzepatide — same situation; compound pharmacies must be 503A or 503B facilities in good standing

What to ask: "Which formulation do you use, and from which pharmacy? What is that pharmacy's accreditation status?"

A legitimate provider can answer this immediately. Vague answers ("our proprietary blend," "pharmaceutical grade") are red flags.

What proper clinical oversight looks like

This is where med spas vary most. A responsible GLP-1 protocol includes:

At intake:

• Body weight, height, BMI
• Medical history review — contraindications include personal/family history of medullary thyroid carcinoma or MEN2 syndrome, pancreatitis history
• Basic labs (at minimum: HbA1c, fasting glucose, lipid panel, comprehensive metabolic panel, thyroid panel)
• Blood pressure assessment
• Current medications review (GLP-1s interact with other diabetes medications)
• Discussion of realistic expectations and side effects

During treatment:

• Monthly (or at minimum quarterly) check-ins
• Lab monitoring as indicated
• Side-effect management guidance (nausea, vomiting, and constipation are common in the first 4–8 weeks; there are protocols to manage these)
• Dose escalation supervised by a clinician

A practice that prescribes GLP-1 medications after a 10-minute intake form with no labs is not practicing safely.

Side effects to know

Common (first 4–12 weeks, often improving over time):

• Nausea (most common; 20–44% in trials)
• Vomiting
• Constipation or diarrhea
• Fatigue
• Injection site reactions

Less common but serious:

• Pancreatitis — stop medication and seek care if you develop severe abdominal pain radiating to your back
• Gallstones — rapid weight loss increases risk; abdominal pain after fatty meals should be evaluated
• Gastroparesis — severely slowed gastric emptying; can occur with extended use
• Muscle loss — weight loss on GLP-1s includes some muscle mass; resistance training and adequate protein (1.2–1.6g/kg) significantly mitigate this

What "Ozempic face" actually means

"Ozempic face" refers to facial hollowing and volume loss that some patients experience with significant weight loss on GLP-1s. This is not a drug-specific side effect — it's a consequence of rapid weight loss from any cause. Fat redistributes from the face along with the rest of the body.

Patients on GLP-1s who experience facial volume loss may benefit from filler consultations once their weight stabilizes. This is one reason med spas offering both GLP-1 programs and injectables are positioned to provide comprehensive care — though it shouldn't be the primary reason you choose a provider.

Questions to ask before starting

• "What labs do you require before prescribing?"
• "Which formulation do you use, and from which compounding pharmacy?"
• "Who is the supervising prescriber, and what are their credentials?"
• "What's the check-in schedule during treatment?"
• "What do I do if I experience significant side effects?"
• "Is this compounded or branded medication?"

A practice that can't answer all of these questions clearly should not be managing your medication.

---

Looking for a weight management provider? Browse wellness providers on MedSpot and check profiles for clinical credentials and GLP-1 program details.